KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX1::RUNX1T1

Overview of attention for article published in Pediatric Blood and Cancer, November 2023

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 46 X posts from 31 X users, with an upper bound of 124,695 followers.

RT @ASPHO_hq: Another PBC must-read: KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX…

RT @ASPHO_hq: Another PBC must-read: KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX…

RT @ASPHO_hq: Another PBC must-read: KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX…

RT @ASPHO_hq: Another PBC must-read: KIT exon 17 mutations are predictive of inferior outcome in pediatric acute myeloid leukemia with RUNX…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 42 additional X posts.